5 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Second-Line Sacituzumab Tirumotecan Plus Anlotinib for Advanced Driver Gene-Negative Non-Squamous NSCLCNeoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmActive, not recruitingPhase 22026-07-14NCT07703228
Impact of Pre-Hospital Heparin Loading in STEMI Patients for Primary PCI: The HELP-PCI-2 TrialInfarction, Necrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, cardiovascular disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, vascular disorderRecruitingNot applicable2026-06-17NCT07361783
Monitoring of Antimicrobial Resistance Based on Metagenomics Analyses in Pneumonia PatientsInfections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorderRecruitingNot stated2026-04-23NCT06566898
The Impact of Transjugular Intrahepatic Portosystemic Shunt on Recompensation in Patients With Decompensated Liver CirrhosisFibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, cirrhosis of liverRecruitingNot stated2025-12-05NCT07172035
Total Infectome Characterization of Eye InfectionsInfections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, disease, eye disorder, eye infectious disorderRecruitingNot stated2025-07-17NCT06775808